Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Biomarker Research|April 12, 2025
The evolving landscape of biomarkers for systemic therapy in advanced hepatocellular carcinomaXinyu Guo, Zhongwei Zhao, Lingyi Zhu, et al.Oncotargets and Therapy|March 11, 2017
<sup>125</sup>I brachytherapy of locally advanced non-small-cell lung cancer after one cycle of first-line chemotherapy: a comparison with best supportive careJingjing Song, Xiaoxi Fan, Zhongwei Zhao, et al.Frontiers in Molecular Biosciences|February 1, 2021
Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective StudyLiyun Zheng, Shiji Fang, Fazong Wu, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 22, 2019
Primary Clinical Application of Y-Shaped Jogged Stent Implantation in Patients with Malignant Hilar Biliary ObstructionZhongwei Zhao, Jingjing Song, Xiaoxi Fan, et al.Redox Biology|October 5, 2016
Synergistic antitumor activity of rapamycin and EF24 via increasing ROS for the treatment of gastric cancerWeiqian Chen, Peng Zou, Zhongwei Zhao, et al.Frontiers in Oncology|May 10, 2021
Corrigendum: LncRNA PCAT6 Induces M2 Polarization of Macrophages in Cholangiocarcinoma via Modulating miR-326 and RhoA-ROCK Signaling PathwayJianfei Tu, Fazong Wu, Li Chen, et al.Frontiers in Oncology|February 8, 2021
Long Non-Coding RNA PCAT6 Induces M2 Polarization of Macrophages in Cholangiocarcinoma <i>via</i> Modulating miR-326 and RhoA-ROCK Signaling PathwayJianfei Tu, Fazong Wu, Li Chen, et al.Journal of Nanobiotechnology|March 4, 2025
Regulation of cancer-associated fibroblasts for enhanced cancer immunotherapy using advanced functional nanomedicines: an updated reviewTingting Liao, Xiaoxiao Chen, Fengkai Qiu, et al.Cell Communication and Signaling : CCS|October 29, 2020
The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinomaBufu Tang, Jinyu Zhu, Jie Li, et al.Cancer Letters|June 18, 2019
Piplartine suppresses proliferation and invasion of hepatocellular carcinoma by LINC01391-modulated Wnt/β-catenin pathway inactivation through ICATXiaoxi Fan, Jingjing Song, Zhongwei Zhao, et al.Pageof 5